Literature DB >> 6363594

Spontaneous internalization of Class I major histocompatibility complex molecules in T lymphoid cells.

D B Tse, B Pernis.   

Abstract

A low proportion of T lymphocytes in normal mouse spleen contains small intracytoplasmic vesicles showing Class I MHC molecules. After stimulation in vitro in a mixed lymphocyte reaction or by addition of Con A, the proportion of T cells with such intracytoplasmic vesicles increases progressively and becomes the majority. Labeling with fluorochrome-conjugated antibodies has shown that the vesicles are formed by internalization of molecules from the plasma membrane. The process is spontaneous and does not require cross-linking by antibodies or other ligands; it is selective inasmuch as other molecules (Thy-1 and T200 antigens) are not included and it is specific since it is not performed by other cells such as B lymphoid cells or fibroblasts. On the whole the process shows similarities with the internalization and recycling of other receptors, such as the receptors for different macromolecules of metabolic or informational significance, as seen in other cells. On the other hand, the specificity of Class I MHC mobilization in T lymphoid cells suggest a role for this process which is related to the immune function of these molecules.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363594      PMCID: PMC2187213          DOI: 10.1084/jem.159.1.193

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Transferrin receptors on human B and T lymphoblastoid cell lines.

Authors:  J W Larrick; P Cresswell
Journal:  Biochim Biophys Acta       Date:  1979-04-03

Review 2.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  An Ia+ subpopulation of activated spleen T cells is generated by concanavalin A stimulation.

Authors:  M Letarte; G Meghji
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

4.  The antibody-induced clustering and endocytosis of HLA antigens on cultured human fibroblasts.

Authors:  C Huet; J F Ash; S J Singer
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

5.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

6.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

8.  Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition.

Authors:  S G Emerson; D B Murphy; R E Cone
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

9.  Transferrin receptor and its recycling in HeLa cells.

Authors:  J D Bleil; M S Bretscher
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction.

Authors:  M C Nussenzweig; R M Steinman
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  24 in total

1.  Internalization of MHC class I molecules is a prerequisite for endocytosis of endorphin by lymphocytes.

Authors:  A M Mommaas; M C Wijsman; W Verduijn; B J Vermeer; F M Claas
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

2.  A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.

Authors:  Raktima Bhattacharya; Yan Xu; Md Ashequr Rahman; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Jon A Weidanz; Ulrich Bickel
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Expression of beta 2-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers.

Authors:  W F Pickl; W Holter; J Stöckl; O Majdic; W Knapp
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

5.  CD4-T-cell antigen receptor complexes on human leukemia T cells.

Authors:  R S Chuck; C R Cantor; D B Tse
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Monoclonal antibodies specific for H-2K and H-2D antigens on cytotoxic T cells can inhibit their function.

Authors:  H C O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules.

Authors:  M A Vega; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Major histocompatibility complex class I-restricted activation of cloned T cells by a soluble protein in the absence of accessory cells.

Authors:  T Dick; A B Reske-Kunz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line.

Authors:  H Körner; H G Burgert
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.

Authors:  D M Roscoe; K Ishikawa; D S Lyles
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.